Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.;Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.
发明人:
申请号：
EP16713818.9
公开号：
EP3274345B1
申请日:
2016.03.24
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to a compound or a pharmaceutically acceptable salt thereof or a solvate thereof or a pharmaceutical composition comprising said compound, a process for obtaining or screening for a toll-like receptor 9 (TLR9) antagonist and a toll-like receptor 9 (TLR9) antagonist or a pharmaceutically acceptable salt thereof or a solvate thereof, preferably being obtainable thereby.
